admin

OTTAWA, ONTARIO–(Marketwired – Jan. 16, 2018) – Tetra Bio-Pharma Inc. (“Tetra” or the “Company“) (TSX VENTURE:TBP)(OTCQB:TBPMF), a global leader in cannabinoid-based drug development and discovery, is pleased to announce that it has received a No Objection Letter (NOL) from the Therapeutic Products Directorate (TPD), Health Canada to evaluate the safety, pharmacokinetics and pharmacodynamics of its […]

by

OTTAWA, ONTARIO–(Marketwired – Jan. 16, 2018) – Tetra Bio-Pharma Inc. (“Tetra” or the “Company“) (TSX VENTURE:TBP)(OTCQB:TBPMF), a global leader in cannabinoid-based drug development and discovery, is pleased to announce that it has received a No Objection Letter (NOL) from the Therapeutic Products Directorate (TPD), Health Canada to evaluate the safety, pharmacokinetics and pharmacodynamics of its […]

by

LONDON and CARLSBAD, Calif., Dec. 29, 2017 (GLOBE NEWSWIRE) — GW Pharmaceuticals plc (Nasdaq:GWPH) (“GW” or “the Company”), a biopharmaceutical company focused on discovering, developing and commercializing novel therapeutics from its proprietary cannabinoid product platform, today announced it has submitted its Marketing Authorisation Application (MAA) to the European Medicines Agency (EMA) for Epidiolex® (cannabidiol or […]

by

For a long time, it’s been a “no-no” to discuss, and for some runners it may have even been a closet recreational activity. But as it gains popularity as legalization continues, more and more athletes are opening the discussion of cannabis use and their training. So, let’s just get right to it: More people are […]

by

American Green, Inc. (OTCMKTS: ERBB) Ties Up With — — USEI (OTC: — — USEI) To Grow Marijuana At California Boston, MA, 08/06/2014 (medicalmarijuanareporter.com) – American Green, Inc. (OTCMKTS: ERBB) announced that along with — — USEI (OTC: — — USEI), it is shifting its focus… … read more at: http://mmjreporter.com/page/178

by

PHOENIX, Dec. 19, 2017 (GLOBE NEWSWIRE) — Can a synthetic formulation of cannabidiol (CBD), one of the main molecules in cannabis, safely help control treatment-resistant “staring†… read more at: http://markets.businessinsider.com/news/stocks/INSYS-Therapeutics-Initiates-Phase-2-Clinical-Trial-of-Cannabidiol-CBD-Oral-Solution-for-Treatment-of-Refractory-Childhood-Absence-Epilepsy-in-Pediatric-PatientsProof-of-concept-study-aims-to-1011641158

by

Cannabinoids are just as effective as existing drugs for the prevention of migraine. For cluster headache, however, cannabinoids may only benefit patients who have experienced migraine since childhood. Researchers say that cannabinoids may be effective for preventing migraine attacks. These are the findings of a new study recently presented at the 3rd Congress of the […]

by

PHOENIX, Dec. 19, 2017 (GLOBE NEWSWIRE) — Can a synthetic formulation of cannabidiol (CBD), one of the main molecules in cannabis, safely help control treatment-resistant “staring†… read more at: http://markets.businessinsider.com/news/stocks/INSYS-Therapeutics-Initiates-Phase-2-Clinical-Trial-of-Cannabidiol-CBD-Oral-Solution-for-Treatment-of-Refractory-Childhood-Absence-Epilepsy-in-Pediatric-PatientsProof-of-concept-study-aims-to-1011641158

by